ENZY — Enzymatica AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK450.79m
- SEK451.88m
- SEK50.90m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 61.3 | 111 | 57.2 | 48.9 | 50.9 |
Cost of Revenue | |||||
Gross Profit | 44.9 | 76 | 33.4 | 28.5 | 31.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 103 | 123 | 102 | 117 | 99 |
Operating Profit | -41.7 | -12.1 | -45.2 | -68.2 | -48.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -41.9 | -13.1 | -45.7 | -68.7 | -49.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -41 | -13.2 | -45.4 | -68.7 | -49.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -41 | -13.2 | -45.4 | -68.7 | -49.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -41 | -13.2 | -45.4 | -68.7 | -49.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.287 | -0.093 | -0.309 | -0.445 | -0.303 |
Dividends per Share |